Related Experiment Video
Updated: May 17, 2025
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Microsurgery alone versus preoperative embolisation: A meta-analysis of outcomes in brain AVMs by Spetzler-Martin
Cyrus Raki1, Lily Davies1, Leon T Lai2
1School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia; Department of Neurosurgery, Monash Health, Level 5, Block D, 246 Clayton Road, Clayton, Victoria 3168, Australia.
Abstract:
Preoperative embolisation is frequently used an adjunct to microsurgery for brain arteriovenous malformations (AVMs), yet high-level evidence supporting its routine use remains limited. This meta-analysis compares outcomes of microsurgery alone versus combined microsurgery and preoperative embolisation, stratified by Spetzler-Martin (SM) grade. A systematic review of Embase, Medline, Scopus, Emcare, and the Cochrane Library identified 43 studies encompassing 3916 patients, equally divided between microsurgery alone (n = 1958) and combination therapy (n = 1958). Primary endpoints included functional dependence (modified Rankin Scale score > 2), angiographic obliteration, haemorrhagic complications, and intraoperative blood loss. Pooled analyses demonstrated no significant differences in functional dependence (OR 0.65, 95 % CI 0.32-1.32, p = 0.21), obliteration rates (OR 1.15, 95 % CI 0.60-2.19, p = 0.63), haemorrhagic complications (OR 1.67, 95 % CI 0.71-3.95, p = 0.20), or intraoperative blood loss (MD -98.90 mL, 95 % CI -417.38-219.57, p = 0.44). Subgroup analysis for SM grade I-II and III-V AVMs found no significant differences in outcomes between treatment modalities. For SM grade III AVMs, angiographic cure rates were comparable, though data scarcity precluded a robust assessment of functional dependence, postoperative haemorrhage, and intraoperative blood loss. While theoretical advantages exist for preoperative embolisation in higher-grade or high-flow AVMs, current evidence does not demonstrate consistent benefits in outcomes or complication rates. Further studies, particularly for SM grade III AVMs, are needed to determine whether combination therapy provides a meaningful advantage over microsurgery alone.
Insights
Preoperative embolization combined with microsurgery for brain arteriovenous malformations (AVMs) shows no significant outcome difference compared to microsurgery alone. Further research is needed for Spetzler-Martin grade III AVMs to clarify potential benefits.
Area of Science:
- Neurosurgery
- Interventional Neuroradiology
- Vascular Neurology
Background:
- Preoperative embolization is a common adjunct to microsurgery for brain arteriovenous malformations (AVMs).
- High-level evidence supporting the routine use of preoperative embolization for AVMs remains limited.
- Treatment decisions are often stratified by Spetzler-Martin (SM) grade.
Purpose of the Study:
- To compare outcomes of microsurgery alone versus combined microsurgery and preoperative embolization for brain AVMs.
- To stratify treatment outcomes based on Spetzler-Martin (SM) grade.
Main Methods:
- Systematic review of multiple databases (Embase, Medline, Scopus, Emcare, Cochrane Library).
- Meta-analysis of 43 studies including 3916 patients (1958 microsurgery alone, 1958 combined therapy).
- Primary endpoints: functional dependence (modified Rankin Scale score > 2), angiographic obliteration, hemorrhagic complications, intraoperative blood loss.
Main Results:
- No significant differences were found in functional dependence, obliteration rates, hemorrhagic complications, or intraoperative blood loss between the two treatment groups.
- Subgroup analysis for SM grades I-II and III-V AVMs showed no significant outcome differences.
- For SM grade III AVMs, while angiographic cure rates were comparable, data scarcity limited robust assessment of other outcomes.
Conclusions:
- Current evidence does not demonstrate consistent benefits of preoperative embolization combined with microsurgery over microsurgery alone for brain AVMs.
- Theoretical advantages for embolization in higher-grade or high-flow AVMs are not consistently supported by outcome data.
- Further studies are required, especially for SM grade III AVMs, to determine the meaningful advantage of combination therapy.
